Late Effects After Allogeneic Stem Cell TransplantationSAVANI, Bipin N.Seminars in hematology. 2012, Vol 49, Num 1, issn 0037-1963, 111 p.Serial Issue

Management of High Ferritin in Long-Term Survivors After Hematopoietic Stem Cell TransplantationBRISSOT, Eolia; SAVANI, Bipin N; MOHTY, Mohamad et al.Seminars in hematology. 2012, Vol 49, Num 1, pp 35-42, issn 0037-1963, 8 p.Article

Management of T-Cell LymphomasREDDY, Nishitha; SAVANI, Bipin N.Seminars in hematology. 2014, Vol 51, Num 1, issn 0037-1963, 88 p.Serial Issue

Gastrointestinal, Hepatobiliary, Pancreatic, and Iron-Related Diseases in Long-Term Survivors of Allogeneic Hematopoietic Cell TransplantationKIDA, Aiko; MCDONALD, George B.Seminars in hematology. 2012, Vol 49, Num 1, pp 43-58, issn 0037-1963, 16 p.Article

Pathogenesis and Treatment of Extranodal Natural Killer/T-Cell LymphomaSUZUKI, Ritsuro.Seminars in hematology. 2014, Vol 51, Num 1, pp 42-51, issn 0037-1963, 10 p.Article

Second Solid Tumors: Screening and Management Guidelines in Long-Term Survivors After Allogeneic Stem Cell TransplantationSOCIE, Gerard; RIZZO, J. Douglas.Seminars in hematology. 2012, Vol 49, Num 1, pp 4-9, issn 0037-1963, 6 p.Article

Can Routine Posttransplant HPV Vaccination Prevent Commonly Occurring Epithelial Cancers after Allogeneic Stem Cell Transplantation?SAVANI, Bipin N; GOODMAN, Stacey; BARRETT, A. John et al.Clinical cancer research (Print). 2009, Vol 15, Num 7, pp 2219-2221, issn 1078-0432, 3 p.Article

Cardiovascular Complications in Long-Term Survivors After Allogeneic Hematopoietic Stem Cell TransplantationROVO, Alicia; TRANSPLANTATION, Marrow.Seminars in hematology. 2012, Vol 49, Num 1, pp 25-34, issn 0037-1963, 10 p.Article

Female Long-Term Survivors After Allogeneic Hematopoietic Stem Cell Transplantation: Evaluation and ManagementSHANIS, Dana; MERIDETH, Melissa; KLEPAC PULANIC, Tajana et al.Seminars in hematology. 2012, Vol 49, Num 1, pp 83-93, issn 0037-1963, 11 p.Article

Challenges to Preventing Infectious Complications, Decreasing Re-hospitalizations, and Reducing Cost Burden in Long-Term Survivors After Allogeneic Hematopoietic Stem Cell TransplantationFUJI, Shigeo; KAPP, Markus; EINSELE, Hermann et al.Seminars in hematology. 2012, Vol 49, Num 1, pp 10-14, issn 0037-1963, 5 p.Article

Dyslipidemia after allogeneic hematopoietic stem cell transplantation: evaluation and managementGRIFFITH, Michelle L; SAVANI, Bipin N; BOORD, Jeffrey B et al.Blood. 2010, Vol 116, Num 8, pp 1197-1204, issn 0006-4971, 8 p.Article

Allogeneic Stem Cell Transplantation for Myelodysplastic SyndromeBARRETT, A. John; SAVANI, Bipin N.Seminars in hematology. 2008, Vol 45, Num 1, pp 49-59, issn 0037-1963, 11 p.Article

Autologous Stem Cell Transplantation for T-Cell LymphomasGIULIA, Perrone; CORRADINI, Paolo.Seminars in hematology. 2014, Vol 51, Num 1, pp 59-66, issn 0037-1963, 8 p.Article

Pathology of Peripheral T-Cell Lymphomas: Where Do We Stand?GAULARD, Philippe; DE LEVAL, Laurence.Seminars in hematology. 2014, Vol 51, Num 1, pp 5-16, issn 0037-1963, 12 p.Article

The Changing Landscape of Peripheral T-Cell Lymphoma in the Era of Novel TherapiesKARLIN, Lionel; COIFFIER, Bertrand.Seminars in hematology. 2014, Vol 51, Num 1, pp 25-34, issn 0037-1963, 10 p.Article

Chronic Kidney Diseases in Long-Term Survivors After Allogeneic Hematopoietic Stem Cell Transplantation: Monitoring and Management GuidelinesABBOUD, Imad; PERALDI, Marie-Noëlle; HINGORANI, Sangeeta et al.Seminars in hematology. 2012, Vol 49, Num 1, pp 73-82, issn 0037-1963, 10 p.Article

Endocrine Complications in Long-Term Survivors After Allogeneic Stem Cell TransplantGUNASEKARAN, Uma; AGARWAL, Neena; JAGASIA, Madan H et al.Seminars in hematology. 2012, Vol 49, Num 1, pp 66-72, issn 0037-1963, 7 p.Article

Chemotherapeutic Advancements in Peripheral T-Cell LymphomaREDDY, Nishitha M; EVENS, Andrew M.Seminars in hematology. 2014, Vol 51, Num 1, pp 17-24, issn 0037-1963, 8 p.Article

Angioimmunoblastic T-Cell Lymphoma ManagementMOSALPURIA, Kailash; BOCIEK, R. Gregory; VOSE, Julie M et al.Seminars in hematology. 2014, Vol 51, Num 1, pp 52-58, issn 0037-1963, 7 p.Article

Quality of Life, Social Challenges, and Psychosocial Support for Long-Term Survivors After Allogeneic Hematopoietic Stem-Cell TransplantationNORKIN, Maxim; HSU, Jack W; WINGARD, John R et al.Seminars in hematology. 2012, Vol 49, Num 1, pp 104-109, issn 0037-1963, 6 p.Article

Novel Therapeutic Strategies for Cutaneous T-Cell Lymphoma in Advanced StagesKUN, Lillian; HERNANDEZ-ILIZALITURRI, Francisco J; REDDY, Nishitha M et al.Seminars in hematology. 2014, Vol 51, Num 1, pp 35-41, issn 0037-1963, 7 p.Article

Long-Term Follow-up and Management Guidelines in Pediatric Patients After Allogenic Hematopoietic Stem Cell TransplantationFRANGOUL, Haydar; NAJJAR, Jennifer; SIMMONS, Jill et al.Seminars in hematology. 2012, Vol 49, Num 1, pp 94-103, issn 0037-1963, 10 p.Article

Bone Loss and Avascular Necrosis of Bone After Hematopoietic Cell TransplantationMCCLUNE, Brian; MAJHAIL, Navneet S; FLOWERS, Mary E. D et al.Seminars in hematology. 2012, Vol 49, Num 1, pp 59-65, issn 0037-1963, 7 p.Article

Allogeneic Transplantation in T-Cell LymphomasSCHMITZ, Norbert; WU, Huei-Shan; GLASS, Bertram et al.Seminars in hematology. 2014, Vol 51, Num 1, pp 67-72, issn 0037-1963, 6 p.Article

How I treat late effects in adults after allogeneic stem cell transplantationSAVANI, Bipin N; GRIFFITH, Michelle L; JAGASIA, Shubhada et al.Blood. 2011, Vol 117, Num 11, pp 3002-3009, issn 0006-4971, 8 p.Article